Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

Cardinal Healthcare recalls Lithium Carbonate Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Products
  • Lithium Carbonate Extended-Release Tablets
Where it was sold

Nationwide USA

Nationwide

Units affected
1 unit
About this recall
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01